Biosafety of milk-derived extracellular vesicles and the mechanism of their cellular uptake

Autores

  • Jing Zhao Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, China , Henan Cancer Hospital image/svg+xml
  • Bei-Bei Chen Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, China , Henan Cancer Hospital image/svg+xml
  • Wei-Feng Xv Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, China , Henan Cancer Hospital image/svg+xml
  • Yang Liu School of Pharmaceutical Sciences, Zhengzhou University, China , Zhengzhou University image/svg+xml
  • Xiao-Bing Chen Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, China; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, China , Zhengzhou University image/svg+xml

DOI:

https://doi.org/10.1590/s2175-97902026e24623

Palavras-chave:

mEV, Biosafety, Immunogenicity, Irritation, Cellular uptake mechanism

Resumo

The biosafety of cow’s milk-derived extracellular vesicles (mEVs) has not been fully explored, particularly regarding its potential as an in vivo drug carrier. This study systematically evaluated the biosafety of mEVs by assessing their in vitro cytotoxicity as well as in vivo toxicity, immunogenicity, and potential for irritation in mice. The results showed that mEVs exhibited minimal cytotoxicity in vitro, with no significant effect on cell viability. Furthermore, repeated injections of mEVs did not induce aberrant immune responses, irritation or toxicity in mice, indicating that mEVs are a highly biocompatible and safe drug carrier with promising biomedical applications. However, further research is needed to fully understand their long-term effects and optimize their use.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Chen W, Wu P, Jin C, Chen Y, Li C, Qian H. Advances in the application of extracellular vesicles derived from three-dimensional culture of stem cells. J Nanobiotechnol. 2024;22(1):215.

Costa Verdera H, Gitz-Francois JJ, Schiffelers RM, Vader P. Cellular uptake of extracellular vesicles is mediated by clathrin-independent endocytosis and macropinocytosis. J Control Release. 2017; 266:100-108.

Gutierrez A, Harvey EL, Creehan KM, Taffe MA. The long-term effects of repeated heroin vapor inhalation during adolescence on measures of nociception and anxiety-like behavior in adult Wistar rats. Psychopharmacology (Berl). 2022;239(12):3939-3952.

Hendrix A, De Wever O. Systemically circulating bacterial extracellular vesicles: origin, fate, and function. Trends Microbiol. 2022;30(3):213-216.

Heusermann W, Hean J, Trojer D, Steib E, von Bueren S, Graff-Meyer A, et al. Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J Cell Biol. 2016;213(2):173-84.

Juodeikis R, Carding SR. Outer Membrane Vesicles: Biogenesis, Functions, and Issues. Microbiol Mol Biol Rev. 2022;86(4):e0003222.

Lang HL, Zhao YZ, Xiao RJ, Sun J, Chen Y, Hu GW, et al. Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes. Neural Regen Res. 2023;18(3):609-617.

Liang YJ, Duan L, Lu JP, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183-3195.

Liu H, Zhang Q, Wang S, Weng W, Jing Y, Su J. Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: Advances and perspectives. Bioact Mater. 2021;14:169-181.

Metselaar JM, Lammers T. Challenges in nanomedicine clinical translation. Drug Deliv Transl Res. 2020, 10(3):721-725.

Ou HR, Csuth TI, Czompoly T, Krisztian K. Dairy: Friend or Foe? Bovine Milk - Derived Extracellular Vesicles and Autoimmune Diseases. Int J Mol Sci. 2024;25(21):11499.

Patel B, Gaikwad S, Prasad S. Exploring the significance of extracellular vesicles: Key players in advancing cancer and possible theranostic tools. cancer pathogenesis&therapy. 2024;02(00):E01-E44.

Rahman MM, Takashima S, Kamatari YO, Shimizu K, Okada A, Inoshima Y. Comprehensive Proteomic Analysis Revealed a Large Number of Newly Identified Proteins in the Small Extracellular Vesicles of Milk from Late-Stage Lactating Cows. Animals (Basel). 2021;11(9):2506.

Senesi G, Lodrini A, Mohammed S, Mosole S, Ceresa D, Bolis S, et al. Human cardiomyocyte derived extracellular vesicles regulate cardiac fibroblast activation through miR-24. Cardiovasc Res. 2024;120(Supplement 1):i44.

Su LY, Tian Y, Zheng Q, Cao Y, Yao M, Wang S, et al. Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor. Cell Chem Biol. 2024;31(6):1219-1230.e5.

Wang L, Wang G, Mao W, Chen Y, Rahman MM, Zhu C, et al. Bioinspired engineering of fusogen and targeting moiety equipped nanovesicles. Nat Commun. 2023;14(1):3366.

Downloads

Publicado

2026-10-06

Declaração de Disponibilidade de Dados

Use of data not disclosed.

Edição

Seção

Article

Como Citar

Biosafety of milk-derived extracellular vesicles and the mechanism of their cellular uptake. (2026). Brazilian Journal of Pharmaceutical Sciences, 62, e24623. https://doi.org/10.1590/s2175-97902026e24623